BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8168997)

  • 21. Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinoma.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Pahl H; Fateh-Moghadam A
    Anticancer Res; 1997; 17(4B):2935-8. PubMed ID: 9329568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of major histocompatibility complex class I and II antigens on survival in colorectal carcinoma.
    Möller P; Momburg F; Koretz K; Moldenhauer G; Herfarth C; Otto HF; Hämmerling GJ; Schlag P
    Cancer Res; 1991 Jan; 51(2):729-36. PubMed ID: 1985791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of two antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in colorectal carcinomas, adenomas, and normal mucosa.
    Bhargava R; Chen B; Klimstra DS; Saltz LB; Hedvat C; Tang LH; Gerald W; Teruya-Feldstein J; Paty PB; Qin J; Shia J
    Cancer; 2006 Apr; 106(8):1857-62. PubMed ID: 16532444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of PDCD4 expression and association with microRNA-21 in each Dukes' stage of colorectal cancer patients.
    Horiuchi A; Iinuma H; Akahane T; Shimada R; Watanabe T
    Oncol Rep; 2012 May; 27(5):1384-92. PubMed ID: 22267128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Collagen XVII expression correlates with the invasion and metastasis of colorectal cancer.
    Moilanen JM; Kokkonen N; Löffek S; Väyrynen JP; Syväniemi E; Hurskainen T; Mäkinen M; Klintrup K; Mäkelä J; Sormunen R; Bruckner-Tuderman L; Autio-Harmainen H; Tasanen K
    Hum Pathol; 2015 Mar; 46(3):434-42. PubMed ID: 25623077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality.
    Al-Mulla F; Going JJ; Sowden ET; Winter A; Pickford IR; Birnie GD
    J Pathol; 1998 Jun; 185(2):130-8. PubMed ID: 9713338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low diacylglycerol values in colonic adenomas and colorectal cancer.
    Sauter G; Nerlich A; Spengler U; Kopp R; Pfeiffer A
    Gut; 1990 Sep; 31(9):1041-5. PubMed ID: 2210451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early detection of liver metastasis in patients with colorectal carcinoma by increased levels of circulating IgA- and IgM-associated secretory component.
    Kvale D; Rognum TO; Brandtzaeg P
    Br J Cancer; 1987 Nov; 56(5):629-32. PubMed ID: 3426927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between tumor-associated glycoprotein 72 mucin levels in tumor and serum of colorectal patients as measured by the quantitative CA 72-4 immunoassay.
    Guadagni F; Roselli M; Cosimelli M; Spila A; Cavaliere F; Tedesco M; Arcuri R; Abbolito MR; Casale V; Pericoli MN; Vecchione A; Casciani CU; Greiner JW; Schlom J
    Cancer Res; 1996 Nov; 56(22):5293-8. PubMed ID: 8912871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histopathological grade, mucinous differentiation and DNA ploidy in relation to prognosis in colorectal carcinoma.
    Purdie CA; Piris J
    Histopathology; 2000 Feb; 36(2):121-6. PubMed ID: 10672056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical detection of p53 and Bcl-2 in colorectal carcinoma: no evidence for prognostic significance.
    Tollenaar RA; van Krieken JH; van Slooten HJ; Bruinvels DJ; Nelemans KM; van den Broek LJ; Hermans J; van Dierendonck JH
    Br J Cancer; 1998 Jun; 77(11):1842-7. PubMed ID: 9667656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer.
    Ganesh S; Sier CF; Griffioen G; Vloedgraven HJ; de Boer A; Welvaart K; van de Velde CJ; van Krieken JH; Verheijen JH; Lamers CB
    Cancer Res; 1994 Aug; 54(15):4065-71. PubMed ID: 8033138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma.
    White JD; Hewett PW; Kosuge D; McCulloch T; Enholm BC; Carmichael J; Murray JC
    Cancer Res; 2002 Mar; 62(6):1669-75. PubMed ID: 11912138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma carcinoembryonic antigen concentrations and immunohistochemical patterns of epithelial marker antigens in patients with large bowel carcinoma.
    Rognum T; Elgjo K; Brandtzaeg P; Orjasaeter H; Bergan A
    J Clin Pathol; 1982 Sep; 35(9):922-33. PubMed ID: 6749906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cathepsin D content in colorectal cancer. Correlation with cathepsin D activity and other biological parameters: a preliminary report.
    Tumminello FM; Gebbia N; Pizzolanti G; Russo A; Bazan V; Leto G
    Oncology; 1995; 52(3):237-42. PubMed ID: 7715907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathologic features of synchronous colorectal carcinoma: A distinct subset arising from multiple sessile serrated adenomas and associated with high levels of microsatellite instability and favorable prognosis.
    Hu H; Chang DT; Nikiforova MN; Kuan SF; Pai RK
    Am J Surg Pathol; 2013 Nov; 37(11):1660-70. PubMed ID: 23887157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inverse correlation between HLA-DR antigen expression and CD4 positive lymphocytic populations in normal mucosa, tubulovillous adenoma, and invasive carcinoma of the colon.
    Tamiolakis D; Venizelos I
    Cesk Patol; 2006 Apr; 42(2):52-8. PubMed ID: 16715627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of different laminin binding proteins in basolateral cell membranes of human colorectal carcinomas and normal colonic mucosa.
    Stallmach A; Riese HH; Schuppan D; Bornhöft G; Stein H; Riecken EO
    Gut; 1991 Mar; 32(3):282-6. PubMed ID: 2013422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemically detectable bcl-2 expression in colorectal carcinoma: correlation with tumour stage and patient survival.
    Ofner D; Riehemann K; Maier H; Riedmann B; Nehoda H; Tötsch M; Böcker W; Jasani B; Schmid KW
    Br J Cancer; 1995 Oct; 72(4):981-5. PubMed ID: 7547253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of cyclin B1 protein expression in colorectal cancer.
    Grabsch H; Lickvers K; Hansen O; Takeno S; Willers R; Stock W; Gabbert HE; Mueller W
    Am J Clin Pathol; 2004 Oct; 122(4):511-6. PubMed ID: 15487447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.